Privacy policy

By using our website, you hereby consent to our Privacy Policy and agree to its terms.

HomeCompany overviewLeadership teamStrategy Advisory BoardPartners & InstitutionsTherapeutic AreasTherapeutic ApproachInnovative Lipid VectorsPipelineGAO-3-02 / GAO-11-02NewsContact

Our commitment is to improve the quality of life of patients with epilepsy and cognitive disorders.

Explore to know more
Scroll down

What we do

DEVELOPING NEW DRUGS

We identify and develop drug candidates with innovative mechanisms of action. By differentiating our approach from existing treatments, we aim at offering new therapeutic options to patients.

Our therapeutic areas
LIPIDS DERIVATIVES

The molecules we develop are lipid derivatives. The robust experience of our team in complex lipid biochemistry enables us to tap the pharmacological potential of these molecules.

Research and development

About us

COMPANY OVERVIEW

GAOMA is a biotech company founded in 2019 and based in Bron, close to Lyon, France. Our team is committed to transform scientific discoveries into adapted therapeutic solutions for patients.

More about us and our team

Latest news

See all
ELLIPSE – INNOVATIONS IN EPILEPSY
Read
EILAT XV – 2020 – GAOMA THERAPEUTICS TO PRESENT GAO-3-02 DRUG CANDIDATE
Read
BIO-EUROPE SPRING DIGITALIZED – 2020 – “STARTUP SPOTLIGHT” SELECTED COMPANY
Read